Isobleomycin A2
| Internal ID | 1c92d645-38de-4781-87f8-7fd3bb5f1b71 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides > Hybrid glycopeptides |
| IUPAC Name | 3-[[2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C55H83N17O21S3/c1-20-33(69-46(72-44(20)58)25(12-31(57)76)64-13-24(56)45(59)82)50(86)71-35(41(26-14-61-19-65-26)91-54-43(39(80)37(78)29(15-73)90-54)92-53-40(81)42(93-55(60)88)38(79)30(16-74)89-53)51(87)66-22(3)36(77)21(2)47(83)70-34(23(4)75)49(85)63-10-8-32-67-28(18-94-32)52-68-27(17-95-52)48(84)62-9-7-11-96(5)6/h14,17-19,21-25,29-30,34-43,53-54,64,73-75,77-81H,7-13,15-16,56H2,1-6H3,(H13-,57,58,59,60,61,62,63,65,66,69,70,71,72,76,82,83,84,85,86,87,88)/p+1 |
| InChI Key | OYVAGSVQBOHSSS-UHFFFAOYSA-O |
| Popularity | 0 references in papers |
| Molecular Formula | C55H84N17O21S3+ |
| Molecular Weight | 1415.60 g/mol |
| Exact Mass | 1414.51898128 g/mol |
| Topological Polar Surface Area (TPSA) | 685.00 Ų |
| XlogP | -7.50 |
| Atomic LogP (AlogP) | -7.70 |
| H-Bond Acceptor | 31 |
| H-Bond Donor | 20 |
| Rotatable Bonds | 35 |
| bleomycin |
| 11056-06-7 |
| Isobleomycin A2 |
| Bleomycin sulfate |
| Bleomycin hydrochloride |
| NCIMech_000876 |
| CHEMBL439180 |
| NSC146842 |
| NSC-146842 |
| 51041-93-1 |
| There are more than 10 synonyms. If you wish to see them all click here. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5651 | 56.51% |
| Caco-2 | - | 0.8605 | 86.05% |
| Blood Brain Barrier | - | 0.8000 | 80.00% |
| Human oral bioavailability | - | 0.8429 | 84.29% |
| Subcellular localzation | Lysosomes | 0.4224 | 42.24% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8016 | 80.16% |
| OATP1B3 inhibitior | + | 0.9346 | 93.46% |
| MATE1 inhibitior | - | 0.9219 | 92.19% |
| OCT2 inhibitior | - | 0.8561 | 85.61% |
| BSEP inhibitior | + | 0.9239 | 92.39% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8608 | 86.08% |
| CYP3A4 substrate | + | 0.7549 | 75.49% |
| CYP2C9 substrate | - | 0.5937 | 59.37% |
| CYP2D6 substrate | - | 0.8498 | 84.98% |
| CYP3A4 inhibition | - | 0.6700 | 67.00% |
| CYP2C9 inhibition | - | 0.7035 | 70.35% |
| CYP2C19 inhibition | - | 0.6794 | 67.94% |
| CYP2D6 inhibition | - | 0.8678 | 86.78% |
| CYP1A2 inhibition | - | 0.7423 | 74.23% |
| CYP2C8 inhibition | + | 0.8553 | 85.53% |
| CYP inhibitory promiscuity | - | 0.8609 | 86.09% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.5607 | 56.07% |
| Eye corrosion | - | 0.9809 | 98.09% |
| Eye irritation | - | 0.8956 | 89.56% |
| Skin irritation | - | 0.7629 | 76.29% |
| Skin corrosion | - | 0.9176 | 91.76% |
| Ames mutagenesis | + | 0.9800 | 98.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7074 | 70.74% |
| Micronuclear | + | 0.7700 | 77.00% |
| Hepatotoxicity | - | 0.7750 | 77.50% |
| skin sensitisation | - | 0.8377 | 83.77% |
| Respiratory toxicity | + | 0.8556 | 85.56% |
| Reproductive toxicity | + | 0.9667 | 96.67% |
| Mitochondrial toxicity | + | 0.8375 | 83.75% |
| Nephrotoxicity | + | 0.7834 | 78.34% |
| Acute Oral Toxicity (c) | III | 0.5873 | 58.73% |
| Estrogen receptor binding | - | 0.5415 | 54.15% |
| Androgen receptor binding | + | 0.8580 | 85.80% |
| Thyroid receptor binding | + | 0.8289 | 82.89% |
| Glucocorticoid receptor binding | + | 0.8396 | 83.96% |
| Aromatase binding | + | 0.8533 | 85.33% |
| PPAR gamma | + | 0.7870 | 78.70% |
| Honey bee toxicity | - | 0.6132 | 61.32% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | - | 0.6500 | 65.00% |
| Fish aquatic toxicity | + | 0.8673 | 86.73% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.62% | 96.09% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 99.17% | 96.21% |
| CHEMBL2581 | P07339 | Cathepsin D | 98.46% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 98.00% | 83.82% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.63% | 91.11% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 97.50% | 94.73% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 97.09% | 92.29% |
| CHEMBL3714130 | P46095 | G-protein coupled receptor 6 | 96.54% | 97.36% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 96.43% | 98.05% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.14% | 94.45% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 95.23% | 99.23% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 95.02% | 96.00% |
| CHEMBL2243 | O00519 | Anandamide amidohydrolase | 93.38% | 97.53% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 92.99% | 96.28% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 92.88% | 90.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.61% | 99.17% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 92.58% | 93.03% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 92.37% | 93.56% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 92.31% | 94.75% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 92.10% | 96.90% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 92.05% | 95.00% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 91.05% | 89.34% |
| CHEMBL226 | P30542 | Adenosine A1 receptor | 90.24% | 95.93% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 89.98% | 88.42% |
| CHEMBL5028 | O14672 | ADAM10 | 89.32% | 97.50% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 88.95% | 97.25% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 88.48% | 95.56% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 88.26% | 95.17% |
| CHEMBL1293277 | O15118 | Niemann-Pick C1 protein | 87.80% | 81.11% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 87.12% | 85.00% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 86.35% | 97.79% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 86.16% | 94.00% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 86.14% | 94.00% |
| CHEMBL1993 | P26358 | DNA (cytosine-5)-methyltransferase 1 | 85.89% | 95.44% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 85.44% | 82.86% |
| CHEMBL2885 | P07451 | Carbonic anhydrase III | 85.17% | 87.45% |
| CHEMBL1881 | P43116 | Prostanoid EP2 receptor | 84.89% | 93.00% |
| CHEMBL2563 | Q9UQL6 | Histone deacetylase 5 | 84.77% | 89.67% |
| CHEMBL3776 | Q14790 | Caspase-8 | 84.58% | 97.06% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 84.52% | 97.09% |
| CHEMBL4071 | P08311 | Cathepsin G | 84.27% | 94.64% |
| CHEMBL4506 | Q96EB6 | NAD-dependent deacetylase sirtuin 1 | 84.25% | 88.33% |
| CHEMBL3784 | Q09472 | Histone acetyltransferase p300 | 84.13% | 93.33% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 84.01% | 100.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 83.59% | 90.71% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 83.56% | 90.08% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 83.55% | 98.33% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 83.30% | 100.00% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 82.54% | 95.71% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 82.26% | 94.33% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 82.20% | 95.52% |
| CHEMBL1287628 | Q9Y5S8 | NADPH oxidase 1 | 81.95% | 95.48% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 81.86% | 91.24% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 81.57% | 93.00% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 81.56% | 94.45% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 81.39% | 97.47% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.35% | 88.56% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 84068 |
| LOTUS | LTS0005551 |
| wikiData | Q105203557 |